Navigation Links
Nottingham Primary Care Division a UK leading center

The University of Nottingham's Division of Primary Care has been invited to join a national partnership in recognition of its excellent research.

The Division is to be part of the National School of Primary Care Research a partnership linking the subject's seven leading academic centres in the UK after its excellent result in the Research Assessment Exercise (RAE) 2008.

Nottingham joins six other universities in the National School: University College London and the universities of Bristol, Birmingham, Manchester, Oxford and Southampton. Like Nottingham, all have had at least 50 per cent of their research rated 'internationally excellent' (3*) or 'world-leading' (4*).

Primary care relates to the health services that play a central role in the local community GPs, pharmacists, dentists and midwives which are normally the first services members of the public turn to when seeking healthcare.

Research groups within the Division of Primary Care, part of The University of Nottingham's School of Community Health Sciences, span a range of important primary care health topics including clinical epidemiology, injury epidemiology and prevention, safe and effective use of medicines, ethnicity, disadvantage and health, applied genetics, and smoking cessation.

Professor Bob Webb, Pro Vice-Chancellor for Research at The University of Nottingham, congratulated everyone involved in achieving this award. "I am sure it will provide a very good platform for the continuing development of international quality research not only in the Medical Faculty, but also of benefit internationally" he said.

Professor Denise Kendrick, Professor of Primary Care Research and Joint Head of the Division of Primary Care with Professor Tony Avery, said: "We think this is an excellent opportunity to continue to develop our primary care research, to strengthen existing collaborations and develop new ones, and to contribute to the development of the discipline nationally.

"Membership of the National School will also place us in a good position to take full advantage of other funding opportunities including those for research capacity development in primary care."

The National School of Primary Care Research formed in October 2006 and is funded by the National Institute for Health Research (NIHR). It currently has a 3 million annual budget for supporting primary care research studies.

The main aims of the National School for Primary Care Research are to increase the evidence base for primary care practice through high quality research to inform the development of clinical practice, and strategic leadership to support the development of research. It recently set up a Primary Care Patient and Public Involvement (PPI) Forum in Manchester to try to involve the public at an early stage in all our research.

This invitation to join the National School of Primary Care Research means the work of Nottingham's researchers will contribute to the NIHR's aspiration to establish the NHS as an internationally recognized centre of research excellence influencing healthcare policy and strategy.


Contact: Professor Tony Avery
University of Nottingham

Related medicine news :

1. UK Center for Tobacco Control Studies to be based in Nottingham
2. Prestigious fellowship for young Nottingham researcher
3. Is 4 agents decoction (Si Wu Tang) efficacious in treating primary dysmenorrhea?
4. Study finds primary care depression treatment often does not follow quality guidelines
5. Primary biliary cirrhosis more severe in African-American and Hispanic patients
6. New research may lead to earlier diagnosis and treatment of primary biliary cirrhosis in families
7. Revisions to College Cost Reduction and Access Act will create barriers to primary care
8. New Hampshire: 1st in the Nation Primary State Takes a Stand on E-Prescribing
9. Editorial says primary care system must change how it approaches dementia
10. S&P: Leverage Tops Politics as Primary Credit Concern for U.S. Health Care Companies, Says S&P
11. ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent
Post Your Comments:
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: